About the Event

In this session, Dr Michael May, President and Chief Executive Officer, Centre for Commercialization of Regenerative Medicine (CCRM) Canada, will address the global landscape for the regenerative medicine industry and the post-pandemic sector impacts and reasons for optimism.

His presentation will include an outline of where the sector stands globally, providing market insights and trends and the impact of COVID-19. He will also address concerns that organisations may have regarding supply chains and ensuring they have capacity and capability at a local level, and will highlight the need to think globally.